Stocks · Health care · Pharmaceutical Preparations

Dyne Therapeutics, Inc.

DYN Clue Score43
United States Fiscal year ends December CIK 0001818794 Results filed 5 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Carlo Incerti
18 Nov 2024
Director
Sold after exercise
16,500
$28.73
$474.05K
Richard William Scalzo
6 Sep 2024
SVP, Head of Finance & Admin.
Sold after exercise
1,700
$32.63
$55.47K
Richard William Scalzo
6 Sep 2024
SVP, Head of Finance & Admin.
Sold after exercise
124,374
$32.14
$4.00M
Showing 250 of 478 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 329
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 9
Sales on a Rule 10b5-1 plan 327
Sales straight out of an exercise 62
Sales at will 64
Transactions with no price 0
Shares from compensation/vesting 51,576,564
Sales filed before the plan box existed 30
History held since 18 Sep 2020